Showing results (61-70 of 240) with videos related to

Sort By:
Pageof 24
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 31, 2014
Total synthesis of (18S)- and (18R)-homolargazole by rhodium-catalyzed hydrocarboxylationChristoph Schotes, Dmytro Ostrovskyi, Johanna Senger, et al.
Pharmacoepidemiology and Drug Safety|May 30, 2012
Use of systemic antifungals in daily clinical practice in the haematology and oncology setting: results of a prospective observational analysisBarbara Metzke, Werner Christian Neubauer, Stefanie Hieke, et al.
Future Medicinal Chemistry|May 22, 2015
Drugging the schistosome zinc-dependent HDACs: current progress and future perspectivesMartin Marek, Guilherme Oliveira, Raymond J Pierce, et al.
Chemmedchem|July 14, 2007
Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins)Johannes Trapp, Rene Meier, Darunee Hongwiset, et al.
Journal of Medicinal Chemistry|February 21, 2019
Cofactor Analogues as Active Site Probes in Lysine AcetyltransferasesRoman P Simon, Tobias Rumpf, Vaida Linkuviene, et al.
The Journal of Organic Chemistry|June 2, 2018
Photochromic Indolyl Fulgimides as Chromo-pharmacophores Targeting SirtuinsNadja A Simeth, Lisa-Marie Altmann, Nathalie Wössner, et al.
Chemmedchem|December 17, 2008
Virtual screening and biological characterization of novel histone arginine methyltransferase PRMT1 inhibitorsRalf Heinke, Astrid Spannhoff, Rene Meier, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 13, 2013
The nephronophthisis gene product NPHP2/Inversin interacts with Aurora A and interferes with HDAC6-mediated cilia disassemblyMiriam Mergen, Christina Engel, Barbara Müller, et al.
Leukemia Research|April 3, 2012
HDAC6 as a target for antileukemic drugs in acute myeloid leukemiaBjörn Hackanson, Leander Rimmele, Marco Benkißer, et al.
Pageof 24